Please use this identifier to cite or link to this item:
|Title:||In situ organ-specific vascularization in tissue engineering||Authors:||Fu, Jiayin
|Keywords:||Engineering::Chemical engineering||Issue Date:||2018||Source:||Fu, J., & Wang, D.-A. (2018). In situ organ-specific vascularization in tissue engineering. Trends in biotechnology, 36(8), 834-849. doi:10.1016/j.tibtech.2018.02.012||Journal:||Trends in biotechnology||Abstract:||Other than a few avascular tissues, almost all human tissues are connected to the systemic circulation via blood vessels that promote metabolism and function. Accordingly, engineered vascularization is a vital goal in tissue engineering for regenerative medicine. Endothelial cells (ECs) play a central role in vascularization with two significant specificities: physical interfaces between vascular stroma and blood, and phenotypic organ-specificity. Biomaterial scaffolding technologies that address these unique properties of ECs have been developed to promote the vascularization of various engineered tissues, and these have advanced from mimicking vascular architectures ex situ towards promoting spontaneous angiogenic remodeling in situ. Simultaneously, endothelial progenitor cells (EPCs) and organ-specific ECs are attracting more and more attention with the increasing awareness of the diversity of ECs in different organs.||URI:||https://hdl.handle.net/10356/142045||ISSN:||0167-7799||DOI:||10.1016/j.tibtech.2018.02.012||Rights:||© 2018 Elsevier Ltd. All rights reserved.||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||SCBE Journal Articles|
Updated on Mar 10, 2021
Updated on Mar 8, 2021
Updated on Jun 25, 2022
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.